Pharmaceuticals Smart Cards and other Access Control system

United Kingdom Arecor Tender

📄 Tender ID: 451800371 📅 Published: 29 Feb 2020

📋 Tender Overview

Arecor Ltd the biopharmaceutical company advancing todays therapies to enable healthier lives announces that it has achieved an important second contractual milestone with one of its pharmaceutical partners. The first milestone was triggered in October 2017 following the signature of a license agreement between the parties. In accordance with the license agreement the partner has rights to further develop manufacture and commercialise a novel superior formulation of a biosimilar product which was developed by Arecor using its proprietary Arestat platform. The novel stable liquid formulation has met agreed intellectual property and improved thermostability specifications for both intravenous IV and subcutaneous SC presentations. Under the terms of the exclusive global royalty bearing license a second milestone payment has been duly triggered.It is expected that the partner will now initiate final pivotal studies in order to further progress the product towards commercialisation which could result in future milestone and royalty payments. Arestat is a world leading innovative and proprietary formulation technology platform which significantly enhances the properties of therapeutic proteins and peptides. Arestat has the unique potential to deliver superior reformulations of existing products which would otherwise not be possible. Sarah Howell Chief Executive Officer of Arecor said The achievement of this second license milestone with our valued partner is an important testament of our ability to develop differentiated formulations of existing products that meet clinical and regulatory requirements. Here we have used Arestat to deliver a superior formulation of a biosimilar product. In doing so not only are we able to help our pharmaceutical partner to differentiate their product in this highly competitive space but we further our ultimate goal of supporting patients to gain access to superior and affordable therapeutic treatment options.

🔍 Key Information

📄
Tender Reference No.
451800371
📅
Publication Date
29 Feb 2020
🌐
Sector
Pharmaceuticals
📝
Notice Type
News
📍
Location
United kingdom

📁 Documents & Downloads

No documents found

🏷️ CPV

No CPV found

Need help with this bid?

Our bid experts can help you find, evaluate & win more tenders.

🎧 Talk to Bid Expert
🕒 Submission deadline
0
days remaining · 29 Feb 2020
🔔 Set Alert

🧭 Quick Facts

Authority N/A
Country United kingdom
State / UT N/A
Tender Type Procurement News
Currency N/A
Similar Tenders
Loading similar tenders…